Since lymph node involvement contributed to poor survival, decreased IDO in lymph node metastases do not support the hypothesis that IDO expressed by metastatic cancer cells contributes to metastasis by direct induction of local immunosuppression [51-55]. The gene discussed is IDO1; the disease is metastatic malignant neoplasm in the lymph nodes.